Richard L. Faherty
President chez pSiMedica Ltd.
Profil
Richard L.
Faherty is currently the President of pSiMedica Ltd.
Previously, he held the position of Executive Vice President-Administration at Bio-Reference Laboratories, Inc. Faherty received his undergraduate degree from the University of Notre Dame in 1968 and his graduate degree from Fordham University in 1975.
Postes actifs de Richard L. Faherty
| Sociétés | Poste | Début |
|---|---|---|
pSiMedica Ltd.
 pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The private company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | President | 29/07/2009 |
Anciens postes connus de Richard L. Faherty
| Sociétés | Poste | Fin |
|---|---|---|
| BIO-REFERENCE LABORATORIES INC | Chief Tech/Sci/R&D Officer | - |
Formation de Richard L. Faherty
| University of Notre Dame | Undergraduate Degree |
| Fordham University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Bio-Reference Laboratories, Inc.
 Bio-Reference Laboratories, Inc. Medical/Nursing ServicesHealth Services Bio-Reference Laboratories, Inc. engages in the provision testing and related services to physicians, clinics, hospitals, long-term care facilities, employers, government units, and correctional institutions. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The firm focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional health care. The company was founded by Marc D. Grodman in 1981 and is headquartered in Elmwood Park, NJ. | Health Services |
pSiMedica Ltd.
pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The private company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Commercial Services |
